ABSTRACT
Acute kidney injury [AKI] is a common and life-threatening complication following coronary artery bypass graft [CABG]. Neutrophil gelatinase-associated lipocalin [NGAL] and Cystatin C have shown to be good predictive factors for AKI. Recently, there has been a growing interest in the use ofhypertonic saline in cardiac operations. The purpose of this study was to evaluate the prophylactic anti-inflammatory effect ofhypertonic saline [Group A] infusion versus normal saline [Group B] on serum NGAL and Cystatin C levels as the two biomarkers of AKI in CABG patients. This randomized double-blinded clinical trial recruited 40 patients undergoing CABG in Tehran Heart Center, Tehran, Iran. After applying exclusion criteria, the effects of preoperative hypertonic saline [294 meq Na] versus normal saline [154 meq Na] infusion on serum NGAL and Cystatin C levels were investigated in three intervals: before surgery and 24 and 48 hours postoperatively. The probable intraoperative or postoperative confounders, including pump time, cross-clamp time, heart rate, systolic and diastolic blood pressures, central venous pressure, arterial pH, partial pressure of arterial oxygen, fraction of inspired oxygen, blood sugar, Na, K, Mg, hemoglobins, white blood cells, hematocrits, and platelets, were recorded and compared between the two groups of study. The study population comprised 40 patients, including 25 [62.5%] males, at a, mean age +/- SD of 61.7 5 +/- 8.13 years. There were no statistically significant differences between the patients' basic, intraoperative, and postoperative characteristics, including intraoperative and postoperative hemodynamic variables and supports such as inotropic use. Intra-aortic balloon pump use and mortality were not seen in our cases. Three patients in the normal saline group and one patient in the hypertonic saline group had serum NGAL levels greater than 400 ng/ml. Moreover, 10 patients in Group A and 17 patients in group B showed a rise in serum Cystatin C levels above 1.16mg/dl. Patients with AKI had significantly elevated NGAL and Cystatin C levels [p value < 0.001], but there were no significant differences in the decrease in the NGAL level in the hypertonic saline group versus the normal saline group [230.91 +/- 92.68 vs. 239.74 +/- 116.58 ng/ml, respectively; p value = 0.792], or in the decrease in the Cystatin C level in the hypertonic saline group versus the normal saline group [1.05 +/- 0.26 vs. 1.06 +/- 0.31, respectively; p value = 0.874]. Pre-treatment of CABG patients with hypertonic saline had no significant effect on serum NGAL and Cystatin C levels compared to the normal saline-receiving group. Our present data, albeit promising, have yet to fully document outcome differences